Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Tomohiro, Itonaga"'
Autor:
Tomohiro Itonaga, Shinji Sugahara, Ryuji Mikami, Tatsuhiko Saito, Takafumi Yamada, Masahiko Kurooka, Sachika Shiraishi, Mitsuru Okubo, Kazuhiro Saito
Publikováno v:
Annals of Medicine, Vol 53, Iss 1, Pp 267-273 (2021)
AbstractBackground This study evaluated the correlation between radiation-induced lung injury (RILI) and dosimetric parameters on computed tomography (CT) images of stage I non-small cell lung cancer (NSCLC) patients undergoing intensity-modulated ra
Externí odkaz:
https://doaj.org/article/506643c2536740d2abe595a0ece6bfbc
Autor:
Yukinori Okada, Tatsuhiko Zama, Tomohiro Itonaga, Ryuji Mikami, Mitsuru Okubo, Shinji Sugahara, Masahiko Kurooka, Motoki Nakai, Koichiro Abe, Mana Yoshimura, Kazuhiro Saito
Publikováno v:
Hellenic Journal of Nuclear Medicine; Jan-Apr2024, Vol. 27 Issue 1, p27-34, 8p
Autor:
Tomohiro Itonaga, Koichi Tokuuye, Ryuji Mikami, Akira Shimizu, Hiroki Sato, Mana Yoshimura, Kiyoaki Tsukahara, Kazuhiro Saito
Publikováno v:
Br J Radiol
Objective: Xerostomia is the most common treatment-related toxicity after radiotherapy (RT) for head and neck carcinoma, reducing the quality of life of patients due to a decrease in salivary gland function. Methods: Salivary gland scintigraphy was p
Autor:
Mitsuru, Okubo, Tomohiro, Itonaga, Tatsuhiko, Saito, Daisuke, Yunaiyama, Ryuji, Mikami, Yukinori, Okada, Shinji, Sugahara, Takahito, Kondo, Koichi, Tokuuye, Kazuhiro, Saito
Publikováno v:
Oncology Letters. 25
Hypothyroidism may occur after definitive radiotherapy in rare cases of early glottic carcinoma. However, to the best of our knowledge, no study to date has examined the risk factors for hypothyroidism specifically after definitive radiotherapy in pa
Publikováno v:
Cureus.
Publikováno v:
Acta Radiologica. 62:42-50
Background Fully human IgG4 programmed cell death-1 (PD-1) immune checkpoint inhibitors are effective against non-small-cell lung cancer (NSCLC). PD-1-targeted antibodies induce autoimmune adverse events that are not caused by conventional chemothera
Autor:
Mitsuru Okubo, Tomohiro Itonaga, Tatsuhiko Saito, Shinji Sugahara, Daisuke Yunaiyama, Sachika Shiraishi, Ryuji Mikami, Koichi Tokuuye, Kazuhiro Saito, Akira Sakurada
Publikováno v:
BJR Open
Objectives: The study aimed to retrospectively investigate the apparent diffusion coefficient (ADC) of primary cervical cancer to examine the recurrence correlations in patients treated with radiotherapy (RT). Methods: The ADC of 31 patients with cer
Autor:
Koichi Tokuuye, Tatsuhiko Saito, Ryuji Mikami, Sachika Shiraishi, Norihiko Ikeda, Hidetsugu Nakayama, Tomohiro Itonaga, Mitsuru Okubo, Shinji Sugahara
Publikováno v:
Journal of Radiation Research
We conducted a Phase II study to evaluate the usefulness of compensator-based non-coplanar intensity-modulated radiotherapy (ncIMRT) for patients with surgically inaccessible Stage I non–small-cell lung cancer (NSCLC). Patients with pathologically
Autor:
Mitsuru Okubo, Ryuji Mikami, Akira Sakurada, Tomohiro Itonaga, Tatsuhiko Saito, Shinji Sugahara, Kazuhiro Saito, Koichi Tokuuye, Sachika Shiraishi, Jinho Park
Publikováno v:
Molecular and Clinical Oncology.
The aim of the present study was to retrospectively investigate the risk factors of local failure for T1 glottic carcinoma irradiated with a prescription dose of 66 Gy. Between July 2006 and December 2017, 64 patients with T1 glottic squamous cell ca
Autor:
Kazuhiro Saito, Sachika Shiraishi, Mitsuru Okubo, Tomohiro Itonaga, Koichi Tokuuye, Tatsuhiko Saito, Ryuji Mikami, Shinji Sugahara
Publikováno v:
The British Journal of Radiology
Objective: To investigate the suitability of the new diameter-based subgroupings of the eighth edition Tumor Node Metastasis (TNM) classification system regarding radiotherapy treatment for early-stage non-small-cell lung cancer (NSCLC), we retrospec